NASDAQ · Biotechnology

Day One Biopharmaceuticals, Inc. (DAWN) Stock

$21.53 +0.00% NASDAQ: DAWN Healthcare

Operating as a clinical-stage biopharmaceutical entity, Day One Biopharmaceuticals, Inc. is dedicated to discovering and commercializing precise therapeutic options for individuals battling genetically defined cancers.

Valuation

MetricValue
Price$21.53
Market Cap$2.22B
P/E Ratio-20.70
P/B Ratio5.05
P/S Ratio14.06
EPS (TTM)$-1.04
52-Week High$21.53
52-Week Low$5.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-23.43%
ROA-21.13%
ROCE-28.56%
Gross Margin89.12%
Operating Margin-80.76%
Net Margin-67.85%
Debt/Equity0.01
Current Ratio8.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$131.0M$158.0M
Operating Profit$-73.0M$-147.0M$-206.0M$-217.0M$-128.0M
Net Profit$-71.0M$-142.0M$-189.0M$-95.0M$-107.0M
EPS$-1.14$-2.02$-2.37$-1.02$-1.04
Op Margin———-165.7%-80.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$290.0M$349.0M$376.0M$583.0M$508.0M
Total Liabilities$9.0M$17.0M$30.0M$80.0M$67.0M
Cash$284.0M$85.0M$231.0M$125.0M$197.0M
Borrowings$0$1.0M$0$3.0M$3.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-49.0M$-110.0M$-147.0M$-78.0M$-104.0M
Investing Cash Flow$-16.0M$-255.0M$125.0M$-233.0M$174.0M
Financing Cash Flow$0$4.0M$0$25.0M$0
Net Cash Flow$241.0M$-199.0M$146.0M$-106.0M$72.0M
Free Cash Flow$-57.0M$-110.0M$-150.0M$-80.0M$-104.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.40
EV / EBITDA-19.24
FCF Yield-4.84%
Quick Ratio7.91
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARVN $8.02 -3.43% -6.94 $517.14M 0.00%
ATXSAstria Therapeutics, Inc. $12.58 +0.00% -7.40 $718.13M 0.00%
AVBP $30.84 -0.55% -8.82 $1.44B 0.00%
ERAS $17.72 -2.42% -23.45 $6.15B 0.00%
GERN $1.34 -4.29% 23.17 $859.64M 0.00%

About Day One Biopharmaceuticals, Inc.

Operating as a clinical-stage biopharmaceutical entity, Day One Biopharmaceuticals, Inc. is dedicated to discovering and commercializing precise therapeutic options for individuals battling genetically defined cancers. A key asset is DAY101, an orally administered, brain-permeable type II pan-rapidly accelerated fibrosarcoma kinase inhibitor, currently undergoing Phase II clinical trials for young patients experiencing recurrent or worsening low-grade glioma. Additionally, the company is advancing Pimasertib, an oral small molecule designed to inhibit mitogen-activated protein kinase kinases 1 and 2. Established in 2018, Day One Biopharmaceuticals, Inc. maintains its primary operations in South San Francisco, California.

Day One Biopharmaceuticals, Inc. is headquartered in US.

Day One Biopharmaceuticals, Inc. (DAWN) stock trades at $21.53 with a market capitalization of $2.22B. The stock is valued at a price-to-earnings (P/E) ratio of -20.70, price-to-book of 5.05, price-to-sales of 14.06. Over the past 52 weeks the stock has ranged between $5.64 and $21.53, and currently trades at its 52-week high.

On profitability, Day One Biopharmaceuticals, Inc. generates a return on equity (ROE) of -23.43%, return on capital employed of -28.56%, an operating margin of -80.76%, a net profit margin of -67.85%.

Official website: dayonebio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides